Children, Perennial Allergic Rhinitis (PAR), l-t growth

Study identifier:SD-005-0414

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the effect of Long-term treatment with Rhinocort Aqua (Budesonide) Nasal Spray in Children with Perennial Allergic Rhinitis.

Medical condition

Perennial Allergic Rhinitis

Phase

Phase 4

Healthy volunteers

No

Study drug

Budesonide, Placebo

Sex

All

Actual Enrollment

209

Study type

Interventional

Age

4 Years - 10 Years

Date

Study Start Date: 01 Jan 2000
Primary Completion Date: 01 Apr 2003
Study Completion Date: 01 Apr 2003

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria